Schall Law Firm Investigates Securities Fraud Claims Against TransMedics Group

bba1409163120e24db84c19e3e83321b 4 TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Securities Fraud Investigation with the Schall Law Firm

LOS ANGELES, Jan. 28, 2025 — The Schall Law Firm, a national shareholder rights law firm, is investigating potential securities law violations on behalf of TransMedics Group, Inc. (NASDAQ: TMDX) investors.

(PRNewsfoto/The Schall Law Firm)

This investigation centers on whether TransMedics made false or misleading statements, or omitted material information. The firm’s investigation follows a January 10, 2025 report from Scorpion Capital alleging that TransMedics engaged in “the most extreme and grotesque healthcare fraud we have encountered,” exploiting vulnerable, terminally ill patients. The report further alleges that patients received substandard organs due to undisclosed, improper incentives.

Shareholders who incurred losses are urged to contact the firm.

Contact Brian Schall at The Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, or via their website at [website address removed] , or by email at [email address removed].

The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors worldwide.

This press release may constitute Attorney Advertising in some jurisdictions.

CONTACT:

The Schall Law Firm 
Brian Schall, Esq.
310-301-3335

SOURCE The Schall Law Firm

elong